Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

moderna-605x340

US Government’s BARDA to fund Moderna’s coronavirus vaccine by $483m

April 17, 2020 Medical Communications, Research and Development BARDA, COVID-19, Moderna, coronavirus, pharma

Moderna has secured $483 million in funding from the Biomedical Advanced Research and Development Authority (BARDA), to drive development and …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

April 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

Hydroxychloroquine dominates the news as the potential COVID-19 treatment has gone through various trials. A Chinese study showed that the …
News

Leaked data show Gilead’s remdesivir allows severe COVID-19 patients to be discharged after six days

April 17, 2020 Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir

The clinical benefit of Gilead’s promising antiviral therapy Remdesivir has been touted in the treatment of severe cases of COVID-19 …
News
gilead-sciences

Gilead halts COVID-19 remdesivir trial due to enrolment issues, efficacy of the drug uncertain

April 16, 2020 Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

A clinical trial in China investigating Gilead’s antiviral therapy remdesivir as a potential treatment for COVID-19 has been placed on …
News
nhs_sign_8

Scottish Medicines Consortium approves new drugs in multiple sclerosis, ulcerative colitis and diabetes

April 15, 2020 Research and Development, Sales and Marketing Biogen, Fambyra, Janssen, NHS, Rimzoic, Sandoz, Sanofi, Scotland, Scottish Medicines Consortium, Stelara, Suliqua, pharma

Medical regulation must still continue even in a global pandemic, and the Scottish Medicines Consortium, (SMC) has ploughed on with …
News
profileleee

Pharmafile.com’s weekly COVID-19 news round-up

April 15, 2020 Research and Development COVID-19, chloroquine, coronavirus, hydroxychloroquine

Hydroxychloroquine dominates the latest coronavirus news this week. The anti-malaria drug, touted by President Trump as an effective COVID-19 treatment, …
News
1_hpv_vaccine

COVID-19 puts more than 117 million children at risk of missing out on measles vaccines

April 15, 2020 Research and Development MMR vaccines, anti vaxx, anti-vaxx, anti-vaxxers, measles

Measles immunisation campaigns in 24 countries have been delayed due to COVID-19, threatening the vaccinations of 117 million Children. The …
News
shutterstock

Sanofi and GSK set aside rivalry with “unprecedented” COVID-19 vaccine partnership

April 15, 2020 Research and Development COVID-19, GSK, Sanofi, coronavirus

Usual rivals Sanofi and GlaxoSmithKline have said they are to put aside competition with the forging of a new “unprecedented …
News

US to suspend funding of the World Health Organization amidst review

April 15, 2020 Research and Development COVID, COVID-19, coronavirus

US President Donald Trump has announced the US will stop funding the World Health Organization due to allegations that they …
News

Patient Experience: Living with type 1 diabetes

April 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, diabetes, feature, patient experience

23-year-old US student Madelyn Lazra recently graduated with a BA in Business Law and certification in International Business, and is …
Feature
astrazeneca_building_white

AstraZeneca to pit blood cancer drug Calquence against COVID-19 with the company’s fastest-ever trial launch

April 14, 2020 Manufacturing and Production, Research and Development AstraZeneca, COVID-19, Calquence, coronavirus, pharma

As the R&D race against COVID-19 continues, AstraZeneca is poised to launch a global, multicentre clinical trial to test its …
News
gilead-sciences

Gilead’s promising COVID-19 drug remdesivir shows benefit in 68% of hospitalised patients

April 14, 2020 Manufacturing and Production, Research and Development COVID-19, Gilead, coronavirus, pharma, remdesivir

Gilead has provided an update on its ongoing efforts against the novel coronavirus, revealing data from a cohort analysis of …
News
cdc_coronavirus_0

Pharmafile.com’s weekly COVID-19 news round-up

April 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

The world looks for a coronavirus cure as Inovio begins human trials for a vaccine while another vaccine is in …
News
dr_molk

Seres Therapeutics appoints Dr Lisa von Moltke as new Chief Medical Officer

April 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Lisa von Moltke has left Aklermes and has joined Seres Therapeutics as its new Chief Medical Officer. Chief Executive …
Appointment
shutterstock_273326141

Roche signs multi-billion dollar RNA-targeted drug discovery deal with Arrakis Therapeutics

April 9, 2020 Research and Development, Sales and Marketing Arrakis, Roche, partnership, pharma

Roche has signed a new partnership with Arrakis Therapeutics in a bid to drive discovery of RNA-targeted small molecule (rSM) …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026